Dr. Jeff Kasher is a known pharmaceutical development change expert with 28 years of experience at Eli Lilly. He is passionate about improving outcomes, bringing patients and research sites into the development process, and dramatically decreasing time to market. Jeff’s expertise includes novel product development for bench through market launch, research and clinical trial leadership, innovation center start-up as well as new industry paradigm creation.
Currently, Jeff serves as the President of Patients Can’t Wait, and is an Advisory Board member for Be the Partner, BlueCloud, and Wake Forest masters in clinical research management program. He advises several multinational Pharmaceutical companies and CROs, and emerging technology companies, and serves on the Board of Catalyst Clinical Research. He has been named one of the CenterWatch “20 Innovators Changing the Face of the Clinical Trials Industry.”
Jeff received a B.S. in Chemistry from Franklin & Marshall College, a Ph.D. in Pharmacology from the State University of New York, and a Post-Doctoral fellowship in Physiology at Yale University School of Medicine.